Log in  First Connection?

Uro ImagingArchives

Role of 18F-PSMA-1007 PET/CT-derived quantitative volumetric tumor parameters in cytoreductive radical prostatectomy selection for patients with low-volume metastatic hormone-sensitive prostate cancer: a retrospective study
Uro Imaging
 6 min.

 Published on 14/02/2025 |  Original article (Full-text)  | Fan Junjie et al. | BMC Cancer 2025; 25(1): 192

Prostate cancer (PCa) is the second most common malignancy in men worldwide, and ranks first in the developed countries [1, 2]. Among new cases of PCa, approximately 12% of patients present with metastatic hormone-sensitive PCa (mHSPC) and up to 20% in high-risk PCa [3]. In the past few years, the therapeutic...

Fully automated segmentation and classification of renal tumors on CT scans via machine learning
Uro Imaging
 4 min.

 Published on 07/02/2025 |  Original article (Full-text)  | Han Jang Hee et al. | BMC Cancer 2025; 25(1): 173

Up to 70% of renal tumors are detected incidentally by imaging [1], which has led to uncertainty among clinicians as to which tumors should be promptly resected. Accordingly, accurate classification and subtyping of renal masses are becoming increasingly important. In this context, two major issues need...

Comparative magnetic resonance imaging-based study of pelvic floor morphology and function before pregnancy and after primigravida vaginal delivery
Uro Imaging
 5 min.

 Published on 31/01/2025 |  Original article (Full-text)  | Lin Xiaonan et al. | BMC Pregnancy and Childbirth 2025; 25(1): 62

The real-world manifestations of pelvic organ prolapse include uterovaginal prolapse, perineal descent, urethrocele, cystocele, enterocele, and rectocele. Pelvic floor dysfunction (PFD) includes urinary and fecal incontinence, urinary frequency, dyspareunia, proctalgia fugax, and chronic pelvic pain...

Screening and prognostic roles of renal volumetry and scintigraphy in the assessment of living kidney transplant donors, considering the early recovery of the residual renal function
Uro Imaging
 4 min.

 Published on 24/01/2025 |  Original article (Full-text)  | Hori Shunta et al. | BMC Nephrology 2024; 26(1): 28

In terms of the prognosis of end-stage renal disease (ESRD), living donor kidney transplantation (LDKT) is superior to deceased donor kidney transplantation and maintenance dialysis [1, 2–3]. Therefore, if potential living kidney donors (LKDs) are available, LDKT is recommended for the treatment...